Oscar Health (NYSE:OSCR) Stock Price Up 9.4% Following Analyst Upgrade

Oscar Health, Inc. (NYSE:OSCR)’s stock price was up 9.4% on Monday after Barclays upgraded the stock from an underweight rating to an equal weight rating. Barclays now has a $18.00 price target on the stock, up from their previous price target of $13.00. Oscar Health traded as high as $16.21 and last traded at $16.3830. Approximately 2,621,389 shares changed hands during trading, a decline of 29% from the average daily volume of 3,718,096 shares. The stock had previously closed at $14.97.

OSCR has been the subject of a number of other reports. Stephens started coverage on shares of Oscar Health in a research note on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price objective for the company. The Goldman Sachs Group began coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target for the company. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Oscar Health has a consensus rating of “Reduce” and a consensus target price of $16.29.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the completion of the sale, the insider directly owned 501,148 shares in the company, valued at approximately $7,652,529.96. The trade was a 36.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $121,737.42. Following the sale, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. This trade represents a 4.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 383,307 shares of company stock valued at $5,919,555. 25.11% of the stock is currently owned by corporate insiders.

Institutional Trading of Oscar Health

Large investors have recently added to or reduced their stakes in the company. LRI Investments LLC lifted its stake in Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after acquiring an additional 975 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of Oscar Health by 4,420.7% during the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after purchasing an additional 1,282 shares during the last quarter. Atlantic Union Bankshares Corp acquired a new position in Oscar Health during the second quarter valued at $33,000. Quarry LP boosted its holdings in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the last quarter. Finally, Tsfg LLC purchased a new stake in Oscar Health in the third quarter valued at $38,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

The firm has a 50-day simple moving average of $15.88 and a two-hundred day simple moving average of $16.99. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of -14.74 and a beta of 1.90. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company’s revenue was up 23.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.22) earnings per share. As a group, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.